251 related articles for article (PubMed ID: 21387262)
1. Polymorphisms in the cytotoxic T-lymphocyte antigen 4 gene and cancer risk: a meta-analysis.
Zhang Y; Zhang J; Deng Y; Tian C; Li X; Huang J; Fan H
Cancer; 2011 Sep; 117(18):4312-24. PubMed ID: 21387262
[TBL] [Abstract][Full Text] [Related]
2. Polymorphisms in the cytotoxic T-lymphocyte antigen 4 gene and acute rejection risk in transplant recipients.
Zhu CL; Huang Q; Liu CH; Xie F
Mol Biol Rep; 2012 Sep; 39(9):8701-8. PubMed ID: 22711308
[TBL] [Abstract][Full Text] [Related]
3. CTLA-4 +49A/G and CT60 gene polymorphisms in primary Sjögren syndrome.
Gottenberg JE; Loiseau P; Azarian M; Chen C; Cagnard N; Hachulla E; Puechal X; Sibilia J; Charron D; Mariette X; Miceli-Richard C
Arthritis Res Ther; 2007; 9(2):R24. PubMed ID: 17341301
[TBL] [Abstract][Full Text] [Related]
4. Lack of association between cytotoxic T-lymphocyte antigen-4 -318C/T polymorphism and cancer risk: a meta-analysis of case-control studies.
Xia W; Shi R; Zheng WL; Ma WL
Technol Cancer Res Treat; 2013 Dec; 12(6):565-74. PubMed ID: 23745791
[TBL] [Abstract][Full Text] [Related]
5. 49A/G and CT60 polymorphisms of the cytotoxic T-lymphocyte-associated antigen 4 gene associated with autoimmune thyroid disease.
Bicek A; Zaletel K; Gaberscek S; Pirnat E; Krhin B; Stopar TG; Hojker S
Hum Immunol; 2009 Oct; 70(10):820-4. PubMed ID: 19559744
[TBL] [Abstract][Full Text] [Related]
6. Association of Cytotoxic T-lymphocyte Antigen-4 Polymorphisms with Malignant Bone Tumor Risk: A Meta-analysis.
Zhang C; Hou WH; Ding XX; Wang X; Zhao H; Han XW; Wang WJ
Asian Pac J Cancer Prev; 2016; 17(8):3785-91. PubMed ID: 27644617
[TBL] [Abstract][Full Text] [Related]
7. Influence of CTLA-4/CD28/ICOS gene polymorphisms on the susceptibility to cervical squamous cell carcinoma and stage of differentiation in the Polish population.
Pawlak E; Karabon L; Wlodarska-Polinska I; Jedynak A; Jonkisz A; Tomkiewicz A; Kornafel J; Stepien M; Ignatowicz A; Lebioda A; Dobosz T; Frydecka I
Hum Immunol; 2010 Feb; 71(2):195-200. PubMed ID: 19913589
[TBL] [Abstract][Full Text] [Related]
8. Association between CTLA-4 exon-1 +49A>G polymorphism and primary biliary cirrhosis risk: a meta-analysis.
Huang Q; Shao F; Wang C; Qiu LJ; Hu YG; Yu JH
Arch Med Res; 2011 Apr; 42(3):235-8. PubMed ID: 21722820
[TBL] [Abstract][Full Text] [Related]
9. Lack of association between CTLA-4 +49A/G and -318C/T polymorphisms and Behçet's disease risk: a meta-analysis.
Zhang YJ; Xu WD; Duan ZH; Liu SS; Pan HF; Ye DQ
Clin Exp Rheumatol; 2012; 30(3 Suppl 72):S46-50. PubMed ID: 23010350
[TBL] [Abstract][Full Text] [Related]
10. Association of cytotoxic T lymphocyte antigen-4 +49A/G polymorphism and cancer risk: An updated meta-analysis.
Gao X; Zhang S; Qiao X; Yao Y; Wang L; Dong D; Ma X; Wang T
Cancer Biomark; 2014; 14(4):287-94. PubMed ID: 24934372
[TBL] [Abstract][Full Text] [Related]
11. CTLA-4, CD28, and ICOS gene polymorphism associations with non-small-cell lung cancer.
Karabon L; Pawlak E; Tomkiewicz A; Jedynak A; Passowicz-Muszynska E; Zajda K; Jonkisz A; Jankowska R; Krzakowski M; Frydecka I
Hum Immunol; 2011 Oct; 72(10):947-54. PubMed ID: 21669243
[TBL] [Abstract][Full Text] [Related]
12. No association of CTLA-4 polymorphisms with susceptibility to Behçet disease.
Du L; Yang P; Hou S; Zhou H; Kijlstra A
Br J Ophthalmol; 2009 Oct; 93(10):1378-81. PubMed ID: 19570770
[TBL] [Abstract][Full Text] [Related]
13. CTLA4 polymorphisms and ophthalmopathy in Graves' disease patients: association study and meta-analysis.
Han S; Zhang S; Zhang W; Li R; Li Y; Wang Z; Xie Y; Mao Y
Hum Immunol; 2006 Aug; 67(8):618-26. PubMed ID: 16916658
[TBL] [Abstract][Full Text] [Related]
14. High incidence of CTLA-4 AA (CT60) polymorphism in renal cell cancer.
Cozar JM; Romero JM; Aptsiauri N; Vazquez F; Vilchez JR; Tallada M; Garrido F; Ruiz-Cabello F
Hum Immunol; 2007 Aug; 68(8):698-704. PubMed ID: 17678726
[TBL] [Abstract][Full Text] [Related]
15. Polymorphisms at +49A/G and CT60 sites in the 3' UTR of the CTLA-4 gene and APECED-related AIRE gene mutations analysis in sporadic idiopathic hypoparathyroidism.
Goswami R; Gupta N; Ray D; Rani R; Tomar N; Sarin R; Vupputuri MR
Int J Immunogenet; 2005 Dec; 32(6):393-400. PubMed ID: 16313305
[TBL] [Abstract][Full Text] [Related]
16. Methylenetetrahydrofolate reductase polymorphisms and breast cancer risk: a meta-analysis from 41 studies with 16,480 cases and 22,388 controls.
Qi X; Ma X; Yang X; Fan L; Zhang Y; Zhang F; Chen L; Zhou Y; Jiang J
Breast Cancer Res Treat; 2010 Sep; 123(2):499-506. PubMed ID: 20135343
[TBL] [Abstract][Full Text] [Related]
17. Polymorphisms in the T cell regulatory gene cytotoxic T lymphocyte antigen 4 influence the rate of acute rejection after liver transplantation.
Tapirdamaz O; Pravica V; Metselaar HJ; Hansen B; Moons L; van Meurs JB; Hutchinson IV; Shaw J; Agarwal K; Adams DH; Day CP; Kwekkeboom J
Gut; 2006 Jun; 55(6):863-8. PubMed ID: 16299026
[TBL] [Abstract][Full Text] [Related]
18. Association between cytotoxic T lymphocyte antigen-4 +49A/G, -1722T/C, and -1661A/G polymorphisms and cancer risk: a meta-analysis.
Geng R; Song F; Yang X; Sun P; Hu J; Zhu C; Zhu B; Fan W
Tumour Biol; 2014 Apr; 35(4):3627-39. PubMed ID: 24307627
[TBL] [Abstract][Full Text] [Related]
19. Genetic polymorphisms in cytotoxic T-lymphocyte antigen 4 and cancer: the dialectical nature of subtle human immune dysregulation.
Sun T; Hu Z; Shen H; Lin D
Cancer Res; 2009 Aug; 69(15):6011-4. PubMed ID: 19638588
[TBL] [Abstract][Full Text] [Related]
20. [Association of CTLA-4 + 49A/G and CT60 gene polymorphism with type 1 diabetes and thyroid autoimmunity].
Jin P; Xiang B; Lin J; Huang G; Zhou WD; Zheng C; Chao C; Zhou ZG
Zhonghua Yi Xue Za Zhi; 2009 May; 89(18):1246-9. PubMed ID: 19595177
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
